{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:13:48Z","timestamp":1794651228590,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bladder cancer is a common malignancy, and the insensitivity of advanced bladder cancer to cisplatin poses an imminent challenge to treatment. Our study aims to identify novel targets that mediate cisplatin responsiveness in bladder cancer. Accordingly, overexpression of the histone demethylase KDM4A in clinical cohorts was found in association with poor prognosis. Tissue culture and animal tests showed that KDM4A pis ro-proliferative in bladder cancer cells. Using co-immunoprecipitation and mass spectrometry methods, we identified that USP7 is an interacting partners in KDM4A protein complex, in which USP7 catalyzes KDM4A proteins deubiquitination that uncouples the proteasome-dependent degradation. In accordance, a positive correlation between USP7 and KDM4A protein expression was noted in bladder cancer clinical samples. Functional validation tests confirmed that USP7 and KDM4A act complementarily to drive bladder cancer cell proliferation. Importantly, cell and animal assays all evidenced that antagonizing the USP7-KDM4A axis would aggravate cisplatin-induced DNA damage and sensitize cisplatin responsiveness.<\/jats:p>","DOI":"10.1038\/s41419-025-08297-2","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T03:33:13Z","timestamp":1766460793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["USP7 promotes chemotherapy resistance and DNA damage response through stabilizing and deubiquitinating KDM4A in bladder cancer"],"prefix":"10.1038","volume":"17","author":[{"given":"Hailang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianxi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Situ","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuchun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"8297_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA cancer J clin. 2024;74:12\u201349.","journal-title":"CA cancer J clin"},{"key":"8297_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"J Alfred Witjes","year":"2024","unstructured":"Alfred Witjes J, Max Bruins H, Carri\u00f3n A, Cathomas R, Comp\u00e9rat E, Efstathiou JA, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines. Eur Urol. 2024;85:17\u201331.","journal-title":"Eur Urol"},{"key":"8297_CR3","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L. Advances in diagnosis and treatment of bladder cancer. BMJ. 2024;384:e076743.","journal-title":"BMJ"},{"key":"8297_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.890172","volume":"9","author":"JY Teoh","year":"2022","unstructured":"Teoh JY, Castellani D. Editorial: recent advances in bladder cancer diagnosis and treatment. Front Surg. 2022;9:890172.","journal-title":"Front Surg"},{"key":"8297_CR5","doi-asserted-by":"publisher","first-page":"6278","DOI":"10.1172\/JCI139597","volume":"130","author":"X Chen","year":"2020","unstructured":"Chen X, Zhang J, Ruan W, Huang M, Wang C, Wang H, et al. Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer. J Clin Investig. 2020;130:6278\u201389.","journal-title":"J Clin Investig"},{"key":"8297_CR6","doi-asserted-by":"crossref","unstructured":"Dobruch J, Oszczud\u0142owski M. Bladder cancer: current challenges and future directions. Medicina. 2021;57:749.","DOI":"10.3390\/medicina57080749"},{"key":"8297_CR7","first-page":"410","volume":"9","author":"EA Lemke","year":"2018","unstructured":"Lemke EA, Shah AY. Management of advanced bladder cancer: an update. J Adv Pract Oncol. 2018;9:410\u20136.","journal-title":"J Adv Pract Oncol"},{"key":"8297_CR8","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1038\/551S34a","volume":"551","author":"C Berdik","year":"2017","unstructured":"Berdik C. Unlocking bladder cancer. Nature. 2017;551:S34\u2013s5.","journal-title":"Nature"},{"key":"8297_CR9","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.trecan.2022.03.007","volume":"8","author":"D Ranti","year":"2022","unstructured":"Ranti D, Bieber C, Wang YS, Sfakianos JP, Horowitz A. Natural killer cells: unlocking new treatments for bladder cancer. Trends cancer. 2022;8:698\u2013710.","journal-title":"Trends cancer"},{"key":"8297_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.eururo.2016.10.008","volume":"71","author":"GW Dy","year":"2017","unstructured":"Dy GW, Gore JL, Forouzanfar MH, Naghavi M, Fitzmaurice C. Global burden of urologic cancers, 1990-2013. Eur Urol. 2017;71:437\u201346.","journal-title":"Eur Urol"},{"key":"8297_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cancergen.2014.11.001","volume":"208","author":"L Guerra-Calderas","year":"2015","unstructured":"Guerra-Calderas L, Gonz\u00e1lez-Barrios R, Herrera LA, Cant\u00fa de Le\u00f3n D, Soto-Reyes E. The role of the histone demethylase KDM4A in cancer. Cancer Genet. 2015;208:215\u201324.","journal-title":"Cancer Genet"},{"key":"8297_CR12","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1002\/ijc.33375","volume":"148","author":"J Sterling","year":"2021","unstructured":"Sterling J, Menezes SV, Abbassi RH, Munoz L. Histone lysine demethylases and their functions in cancer. Int J Cancer. 2021;148:2375\u201388.","journal-title":"Int J Cancer"},{"key":"8297_CR13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.drudis.2020.10.028","volume":"26","author":"L Nininahazwe","year":"2021","unstructured":"Nininahazwe L, Liu B, He C, Zhang H, Chen ZS. The emerging nature of Ubiquitin-specific protease 7 (USP7): a new target in cancer therapy. Drug Discov today. 2021;26:490\u2013502.","journal-title":"Drug Discov today"},{"key":"8297_CR14","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1016\/j.jmb.2017.05.028","volume":"429","author":"RQ Kim","year":"2017","unstructured":"Kim RQ, Sixma TK. Regulation of USP7: a high incidence of E3 complexes. J Mol Biol. 2017;429:3395\u2013408.","journal-title":"J Mol Biol"},{"key":"8297_CR15","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.str.2016.05.020","volume":"24","author":"L Roug\u00e9","year":"2016","unstructured":"Roug\u00e9 L, Bainbridge TW, Kwok M, Tong R, Di Lello P, Wertz IE, et al. Molecular understanding of USP7 substrate recognition and C-terminal activation. Structure. 2016;24:1335\u201345.","journal-title":"Structure"},{"key":"8297_CR16","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1158\/0008-5472.CAN-12-4300","volume":"73","author":"WL Berry","year":"2013","unstructured":"Berry WL, Janknecht R. KDM4\/JMJD2 histone demethylases: epigenetic regulators in cancer cells. Cancer Res. 2013;73:2936\u201342.","journal-title":"Cancer Res"},{"key":"8297_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-024-02951-0","volume":"19","author":"FH Kakamad","year":"2024","unstructured":"Kakamad FH, Mustafa MN, Yasin SW, Xalid SS, Mohammed AA, Othman S, et al. Carotid body tumor: characteristics and surgical outcome. J Cardiothorac Surg. 2024;19:473.","journal-title":"J Cardiothorac Surg"},{"key":"8297_CR18","doi-asserted-by":"crossref","unstructured":"Gu R, Kim TD, Song H, Sui Y, Shin S, Oh S, et al. SET7\/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A. JCI insight. 2023;8:e164990.","DOI":"10.1172\/jci.insight.164990"},{"key":"8297_CR19","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41419-023-06024-3","volume":"14","author":"Y Hou","year":"2023","unstructured":"Hou Y, Yu W, Wu G, Wang Z, Leng S, Dong M, et al. Carcinogenesis promotion in oral squamous cell carcinoma: KDM4A complex-mediated gene transcriptional suppression by LEF1. Cell Death Dis. 2023;14:510.","journal-title":"Cell Death Dis"},{"key":"8297_CR20","doi-asserted-by":"crossref","unstructured":"Couteau F, Gagn\u00e9 LM, Boulay K, Rousseau P, Carbonneau M, McQuaid M, et al. R-2-hydroxyglutarate-mediated inhibition of KDM4A compromises telomere integrity. Nucleic Acids Res. 2025;53:gkaf512.","DOI":"10.1093\/nar\/gkaf512"},{"key":"8297_CR21","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s12276-021-00657-0","volume":"53","author":"J Zhao","year":"2021","unstructured":"Zhao J, Li B, Ren Y, Liang T, Wang J, Zhai S, et al. Histone demethylase KDM4A plays an oncogenic role in nasopharyngeal carcinoma by promoting cell migration and invasion. Exp Mol Med. 2021;53:1207\u201317.","journal-title":"Exp Mol Med"},{"key":"8297_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.canlet.2013.04.009","volume":"336","author":"M Kogure","year":"2013","unstructured":"Kogure M, Takawa M, Cho HS, Toyokawa G, Hayashi K, Tsunoda T, et al. Deregulation of the histone demethylase JMJD2A is involved in human carcinogenesis through regulation of the G(1)\/S transition. Cancer Lett. 2013;336:76\u201384.","journal-title":"Cancer Lett"},{"key":"8297_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103407","volume":"77","author":"J Zhang","year":"2024","unstructured":"Zhang J, Xu H, He Y, Zheng X, Lin T, Yang L, et al. Inhibition of KDM4A restricts SQLE transcription and induces oxidative stress imbalance to suppress bladder cancer. Redox Biol. 2024;77:103407.","journal-title":"Redox Biol"},{"key":"8297_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.dnarep.2019.02.005","volume":"76","author":"A Pozhidaeva","year":"2019","unstructured":"Pozhidaeva A, Bezsonova I. USP7: structure, substrate specificity, and inhibition. DNA Repair. 2019;76:30\u20139.","journal-title":"DNA Repair"},{"key":"8297_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101077","volume":"297","author":"NA Snyder","year":"2021","unstructured":"Snyder NA, Silva GM. Deubiquitinating enzymes (DUBs): regulation, homeostasis, and oxidative stress response. J Biol Chem. 2021;297:101077.","journal-title":"J Biol Chem"},{"key":"8297_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fcell.2020.00233","volume":"8","author":"SM Qi","year":"2020","unstructured":"Qi SM, Cheng G, Cheng XD, Xu Z, Xu B, Zhang WD, et al. Targeting USP7-mediated deubiquitination of MDM2\/MDMX-p53 pathway for cancer therapy: are we there yet? Front Cell Dev Biol. 2020;8:233.","journal-title":"Front Cell Dev Biol"},{"key":"8297_CR27","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4685-gmb-2021-0058","volume":"44","author":"X Yang","year":"2021","unstructured":"Yang X, Jin J, Yang J, Zhou L, Mi S, Qi G. Expression of ubiquitin-specific protease 7 in oral squamous cell carcinoma promotes tumor cell proliferation and invasion. Genet Mol Biol. 2021;44:e20210058.","journal-title":"Genet Mol Biol"},{"key":"8297_CR28","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/hep.27682","volume":"61","author":"JB Cai","year":"2015","unstructured":"Cai JB, Shi GM, Dong ZR, Ke AW, Ma HH, Gao Q, et al. Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression. Hepatol. 2015;61:1603\u201314.","journal-title":"Hepatol"},{"key":"8297_CR29","doi-asserted-by":"crossref","unstructured":"Shin SB, Kim CH, Jang HR, Yim H. Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance. Int J Mol Sci. 2020;21:8629.","DOI":"10.3390\/ijms21228629"},{"key":"8297_CR30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/apm.13100","volume":"129","author":"Q Xue","year":"2021","unstructured":"Xue Q, Yang D, Zhang J, Gan P, Lin C, Lu Y, et al. USP7, negatively regulated by miR-409-5p, aggravates hypoxia-induced cardiomyocyte injury. APMIS. 2021;129:152\u201362.","journal-title":"APMIS."},{"key":"8297_CR31","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1096\/fj.201902584R","volume":"34","author":"DH Lee","year":"2020","unstructured":"Lee DH, Kim GW, Jeon YH, Yoo J, Lee SW, Kwon SH. Advances in histone demethylase KDM4 as cancer therapeutic targets. FASEB J. 2020;34:3461\u201384.","journal-title":"FASEB J."},{"key":"8297_CR32","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.bbrc.2007.05.179","volume":"359","author":"S Shin","year":"2007","unstructured":"Shin S, Janknecht R. Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. Biochem Biophys Res Commun. 2007;359:742\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"8297_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.685","volume":"5","author":"L Cheng","year":"2024","unstructured":"Cheng L, Yang C, Lu J, Huang M, Xie R, Lynch S, et al. Oncogenic SLC2A11-MIF fusion protein interacts with polypyrimidine tract binding protein 1 to facilitate bladder cancer proliferation and metastasis by regulating mRNA stability. MedComm. 2024;5:e685.","journal-title":"MedComm"},{"key":"8297_CR34","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1177\/1747493018778713","volume":"13","author":"D Sacks","year":"2018","unstructured":"Sacks D, Baxter B, Campbell BCV, Carpenter JS, Cognard C, Dippel D, et al. Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int J Stroke. 2018;13:612\u201332.","journal-title":"Int J Stroke"},{"key":"8297_CR35","first-page":"135","volume":"618","author":"JA Daniel","year":"2007","unstructured":"Daniel JA, Grant PA. Multi-tasking on chromatin with the SAGA coactivator complexes. Mutat Res. 2007;618:135\u201348.","journal-title":"Mutat Res"},{"key":"8297_CR36","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1038\/s41401-022-00890-x","volume":"43","author":"JH Liu","year":"2022","unstructured":"Liu JH, Yang HL, Deng ST, Hu Z, Chen WF, Yan WW, et al. The small molecule chemical compound cinobufotalin attenuates resistance to DDP by inducing ENKUR expression to suppress MYH9-mediated c-Myc deubiquitination in lung adenocarcinoma. Acta Pharmacol Sin. 2022;43:2687\u201395.","journal-title":"Acta Pharmacol Sin"},{"key":"8297_CR37","doi-asserted-by":"publisher","first-page":"6404","DOI":"10.1128\/MCB.25.15.6404-6414.2005","volume":"25","author":"D Zhang","year":"2005","unstructured":"Zhang D, Yoon HG, Wong J. JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2\/Hash2). Mol Cell Biol. 2005;25:6404\u201314.","journal-title":"Mol Cell Biol"},{"key":"8297_CR38","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41419-023-05938-2","volume":"14","author":"K Xiao","year":"2023","unstructured":"Xiao K, Peng S, Lu J, Zhou T, Hong X, Chen S, et al. UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer. Cell Death Dis. 2023;14:408.","journal-title":"Cell Death Dis"},{"key":"8297_CR39","doi-asserted-by":"crossref","unstructured":"AbuHaweeleh MN, Therachiyil L, Prabhu KS, Khan OM, Uddin S. SKP2 E3 ligase in urological malignancies: a critical regulator of the cell cycle and therapeutic target. Cell cycle. 2025;24:1\u201315.","DOI":"10.1080\/15384101.2025.2526211"},{"key":"8297_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202408311","volume":"12","author":"K Xiong","year":"2025","unstructured":"Xiong K, Chen S, Xu H, Tu S, Weng H, Wang Y, et al. RNF112 facilitates ubiquitin-mediated degradation of c-Myc, suppressing proliferation, migration and lipid synthesis in bladder cancer. Adv Sci. 2025;12:e2408311.","journal-title":"Adv Sci"},{"key":"8297_CR41","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nrm2767","volume":"10","author":"I Dikic","year":"2009","unstructured":"Dikic I, Wakatsuki S, Walters KJ. Ubiquitin-binding domains\u2014from structures to functions. Nat Rev Mol Cell Biol. 2009;10:659\u201371.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8297_CR42","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1038\/sj.onc.1210413","volume":"26","author":"A Adhikari","year":"2007","unstructured":"Adhikari A, Xu M, Chen ZJ. Ubiquitin-mediated activation of TAK1 and IKK. Oncogene. 2007;26:3214\u201326.","journal-title":"Oncogene"},{"key":"8297_CR43","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1007\/s10238-023-01075-4","volume":"23","author":"P Huang","year":"2023","unstructured":"Huang P, Wang Y, Zhang P, Li Q. Ubiquitin-specific peptidase 1: assessing its role in cancer therapy. Clin Exp Med. 2023;23:2953\u201366.","journal-title":"Clin Exp Med"},{"key":"8297_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2019.100663","volume":"48","author":"S Narayanan","year":"2020","unstructured":"Narayanan S, Cai CY, Assaraf YG, Guo HQ, Cui Q, Wei L, et al. Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance. Drug Resist Updat. 2020;48:100663.","journal-title":"Drug Resist Updat"},{"key":"8297_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05962-6","volume":"22","author":"J Gu","year":"2024","unstructured":"Gu J, Xiao X, Zou C, Mao Y, Jin C, Fu D, et al. Ubiquitin-specific protease 7 maintains c-Myc stability to support pancreatic cancer glycolysis and tumor growth. J Transl Med. 2024;22:1135.","journal-title":"J Transl Med"},{"key":"8297_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1427663","volume":"14","author":"X Li","year":"2024","unstructured":"Li X, Pan J, Zheng P. USP7 regulates growth and maintains the stemness of p53-mutant colorectal cancer cells via stabilizing of mutant p53. Front Oncol. 2024;14:1427663.","journal-title":"Front Oncol"},{"key":"8297_CR47","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41419-024-06898-x","volume":"15","author":"L Peng","year":"2024","unstructured":"Peng L, Zhao Y, Tan J, Hou J, Jin X, Liu DX, et al. PRMT1 promotes Warburg effect by regulating the PKM2\/PKM1 ratio in non-small cell lung cancer. Cell Death Dis. 2024;15:504.","journal-title":"Cell Death Dis"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08297-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08297-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08297-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T18:02:55Z","timestamp":1769536975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08297-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8297"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08297-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal experiments in this study have been approved by the Laboratory Animal Ethics Committee of the First Affiliated Hospital of Nanchang University. The animal experiments were conducted under the supervision and approval of the ethics committee, and all methods used in the animal experiments were carried out in accordance with relevant guidelines and regulations. The animal experiment ethics certificate number is: CDYFY-IACUC-(202305QR020). The use of surgically removed human tissue samples in this study has been approved by the Medical Research Ethics Committee of the First Affiliated Hospital of Nanchang University, and informed consent from patients has been obtained for their participation in this study. The collection, use, and disposal of surgically removed tissues were all carried out under the approval and supervision of the ethics committee. The collection and use of human tissues were carried out in accordance with the guidelines and regulations, and met the requirements of the ethics committee. The medical research ethics certificate number is: (2022)CDYFYYLK(11\u2013031).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"123"}}